In yesterday’s Wall Street session, Vigil Neuroscience Inc (NASDAQ:VIGL) shares traded at $1.63, up 3.16% from the previous session.
VIGL stock price is now -44.98% away from the 50-day moving average and -51.68% away from the 200-day moving average. The market capitalization of the company currently stands at $66.23M.
On December 19, 2023, Morgan Stanley Downgraded its previous ‘Equal-Weight’ rating to ‘Underweight’ on the stock reducing its target price from $13 to quote $4, while ‘JMP Securities’ rates the stock as ‘Mkt Outperform’
In other news, Budd Haeberlein Samantha L., Director bought 12,000 shares of the company’s stock on Dec 19 ’24. The stock was bought for $20,520 at an average price of $1.71. Upon completion of the transaction, the Director now directly owns 12,000 shares in the company, valued at $19560.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 19 ’24, President and CEO Magovcevic-Liebisch Ivana bought 5,000 shares of the business’s stock. A total of $8,400 was incurred on buying the stock at an average price of $1.68. This leaves the insider owning 222,687 shares of the company worth $0.36 million. A total of 52.63% of the company’s stock is owned by insiders.
During the past 12 months, Vigil Neuroscience Inc has had a low of $1.54 and a high of $6.06. As of last week, the company has a debt-to-equity ratio of 0.15, a current ratio of 3.72, and a quick ratio of 3.72. The fifty day moving average price for VIGL is $3.0016 and a two-hundred day moving average price translates $3.38105 for the stock.
The latest earnings results from Vigil Neuroscience Inc (NASDAQ: VIGL) was released for 2024-06-30.
